Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ) is a China-based pharmaceutical manufacturer and R&D company under Sino Biopharmaceutical Limited. It develops, produces, and markets prescription medicines and active pharmaceutical ingredients (APIs), with core therapeutic focuses in hepatology, oncology, respiratory diseases, cardiovascular conditions, and anti-infectives.
CTTQ operates GMP-compliant facilities and integrated R&D and manufacturing capabilities spanning process development, API synthesis, and finished dosage forms such as injectables and oral solids. The company serves the domestic Chinese market and selected international markets through a portfolio that includes innovative and generic small‑molecule drugs, supported by clinical development and pharmacovigilance systems. Its operations are centered in Jiangsu Province, China.
To provide comprehensive coverage, we aggregate data and news under the name Chia Tai Tianqing, encompassing the following company names, divisions, and related entities:
CTTQ.
This list encompasses current and former names, alternate names, and key divisions associated with Chia Tai Tianqing, ensuring you can easily find all relevant information under a single, unified profile.
